Axa’s Dorman Products DORM Stock Holding History

Axa’s Portfolio DORM Stock Details DORM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,620	Closed	-$567K	–	356
2025 Q2	$567K	Buy	+4,620	New	+$562K	﹤0.01%	975

Other funds holding DORM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Axa's DORM Position: Q3 2025 in Review

Axa sold out of Dorman Products (DORM) in Q3 2025, closing a stake of 4,620 shares — an estimated $567K sold.

Axa first reported a position in DORM in Q2 2025 and held it in 1 quarter. The position peaked at $567K in Q2 2025. 345 funds tracked by Wall St. Rank hold DORM as of Q3 2025.

Axa reported no remaining Dorman Products position as of Q3 2025 after selling out during the quarter.
Axa sold 4,620 Dorman Products shares in Q3 2025, an estimated $567K.
Axa first reported a position in Dorman Products in Q2 2025 and held it in 1 quarter.
Axa's Dorman Products position peaked at $567K in Q2 2025.
345 funds tracked by Wall St. Rank held Dorman Products as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.